Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2500294 | Farmacia Hospitalaria | 2010 | 10 Pages |
Abstract
In each of the cases, pemetrexed was used as a second-line treatment or higher with a good safety profile. A complete or partial response was not reached in any of the cases, but survival after beginning pemetrexed was equal to or longer than that achieved in other studies.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
S. Villanueva-Herraiz, M.P. Ortega-GarcÃa, C. Camps-Herrero, P. Blasco-Segura,